Cadre Financial Ratios
NYSE: CDREHealth CareIndustrial SpecialtiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Cadre ratio analysis
Cadre earned a net margin of 7.2% in FY 2025, up from 6.4% a year earlier. Gross margin was 42.5% compared with a median of 39.9% over the prior 5 years. Return on equity reached 13.9%, meaning Cadre generated 0.14 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.97 versus 0.72 the year before, and the current ratio was 3.50. At the end of FY 2025, CDRE traded at 40.3 times earnings; across the 5 fiscal years shown, its year-end P/E ranged from 32.2 to 125.9, with a median of 40.3. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Cadre financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 40.31 | 36.20 | 32.25 | 125.88 | 57.77 | — |
| Price / sales | 2.75 | 2.29 | 2.56 | 1.59 | 1.70 | — |
| Price / book | 5.29 | 4.18 | 6.26 | 4.38 | 8.20 | — |
| Gross margin | 42.5% | 41.1% | 41.6% | 38.4% | 39.9% | 37.8% |
| Operating margin | 11.0% | 11.8% | 11.7% | 3.7% | 12.1% | 12.3% |
| Net margin | 7.2% | 6.4% | 8.0% | 1.3% | 3.0% | 9.5% |
| Free cash flow margin | 9.3% | 4.6% | 13.8% | 9.2% | 8.7% | 10.1% |
| Return on equity (ROE) | 13.9% | 11.6% | 19.6% | 3.5% | 14.3% | 434.4% |
| Return on assets (ROA) | 5.7% | 5.5% | 9.0% | 1.5% | 4.1% | 13.6% |
| Debt / equity | 0.97 | 0.72 | 0.71 | 0.90 | 1.95 | 24.44 |
| Current ratio | 3.50 | 3.48 | 2.58 | 2.50 | 2.14 | 1.88 |
| Revenue growth | 7.5% | 17.6% | 5.4% | 7.1% | 5.6% | — |
| EPS growth | 13.3% | -11.8% | 537.5% | -63.6% | -68.6% | — |